Biohaven Ltd (BHVN)
$15.42 -6.49% Close Oct 30, 2026 Live
Biohaven stock today
Biohaven closed at $15.42 on October 30, 2026, down 6.49% on the day. Over the past year it returned -11.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.32 billion.
$10.00$15.00
NovJan 2026MarMayJulSep
| Period | BHVN | S&P 500 (SPY) |
|---|---|---|
| 1 month | +15.5% | -0.9% |
| 3 months | +11.6% | +2.1% |
| Year to date | +36.6% | +11.7% |
| 1 year | -11.3% | +12.4% |
| 3 years | -44.2% | +88.5% |
Key statistics
- Market value
- $2.32B
- 52-week range
- $7.79 to $17.39
About Biohaven
Develops and commercializes pharmaceutical treatments for neurological and psychiatric disorders.
Sector: Health Care
More on Biohaven
- Returns: what $1,000 became$1,000 three years ago is $558.09 today
No forecast, no recommendation. This page describes Biohaven Ltd from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.